Phase Genomics, a US-based biotech spinout of University of Washington, has raised $1m from Washington Research Foundation, which invests in companies linked to universities in the US state, and Congruent Ventures, Geekwire reported on Sunday.
Founded in 2015, Phase Genomics was the first spinout to emerge out of the Genome Sciences department at the university. The company has created technology to identify individual micro-organisms and viruses and figure out which of them are commingling inside cells.
The spinout was co-founded by Ivan Liachko and Shawn Sullivan, who launched the business out of the university’s CoMotion biotech incubator, where the company remains.
Phase Genomics currently has three products and services for DNA sequencing on the market, and hopes to launch additional ones in the near future. The funding will be used to hire additional staff.
